- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07815340
Effects Of Criteria Versus Time-Based Rehabilitation On Return To Play In Football Players
September 6, 2026 updated by: Riphah International University
This randomized controlled trial compares criteria-based rehabilitation (CBR) with time-based rehabilitation (TBR) for football players aged 18-35 with ACL reconstruction, hamstring strain, or ankle sprain.
Both groups receive a six-week supervised rehabilitation program; the progression rules differ between groups.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Eligible football players will be recruited from local football clubs and academies in Islamabad Capital Territory and Rawalpindi.
Written informed consent will be obtained.
Participants will be randomly allocated 1:1 using a concealed, computer-generated sequence.
Baseline demographic, functional, and psychological measures will be collected.
Both groups follow the same general phase-based rehabilitation structure under licensed physiotherapist supervision.
CBR progression depends on objective functional and psychological milestones; TBR progression follows fixed time intervals and return-to-play clearance at week 6 irrespective of milestones.
Progression is paused or regressed if pain is ≥4/10 on VAS or swelling returns.
Study Type
Interventional
Enrollment (Estimated)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Saadia Batool
- Phone Number: 03165131870
- Email: saadia.batool@riphah.edu.pk
Study Contact Backup
- Name: rida zafar
- Phone Number: 03368753273
- Email: rida.zafar@riphah.edu.pk
Study Locations
-
-
Federal
-
Islamabad, Federal, Pakistan, 051
- Mescon Islamabad football academy
-
Contact:
- Saadia Batool
- Phone Number: 03165131870
- Email: saadiabatool@riphah.edu.pk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Injury Type: ACL reconstruction, hamstring strain, and ankle sprain.
- Rehabilitation Phase: Phase 3 for ACL injuries, Phase 1&2 for hamstring strains and ankle sprains.
- Football Activity: Active at club or regional football level
Exclusion Criteria:
- History of Major surgery in affected limb
- Chronic neurological or musculoskeletal disorder
- Non-football athletes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Criteria based rehabilitation
Participants in this group will undergo a 6-week criteria-based rehabilitation program,consisting of 3-5 supervised sessions per week, each lasting 45-60 minutes.
Exercise intensity will be progressively increased from low (40-50% of maximum effort) during early phases to high intensity (70-85%) in later stages, depending on individual performance and pain tolerance.
Progression will depend on achieving specific functional and psychological benchmarks rather than elapsed time.
|
Participants will only progress or return to play upon meeting the criteria: hop test LSI ≥ 90%, SEBT symmetry, improved ACLRSI, |
|
Active Comparator: Time based rehabilitation
Participants in this group will follow a fixed 6-week time-based program with 3-5 sessions per week (45-60 minutes/session).
Exercise intensity will progress automatically from low to high each week, regardless of functional test results.
|
Weeks 1-2: Pain reduction and early strengthening (low intensity, 3 sets of 10-12 reps).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hop battery test (single, triple, and crossover hop) including limb symmetry index (LSI)
Time Frame: At baseline, 0 weeks 6 weeks post-intervention
|
A tool to assess lower-limb strength, power, symmetry and functional performance in athletes post-injury; demonstrates good test-retest reliability (ICC ≈ 0.85-0.97)
and valid discriminatory ability, though its capacity to predict re-injury remains inconsistent
|
At baseline, 0 weeks 6 weeks post-intervention
|
|
Star Excursion Balance Test (SEBT/Y-Balance)
Time Frame: At Baseline After 6 weeks
|
Evaluates dynamic balance and postural control; high reliability (ICC 0.85-0.91)
and validated in athletes
|
At Baseline After 6 weeks
|
|
ACL-RSI (Return to Sport after Injury Scale)
Time Frame: At baseline After 6 weeks of intervention
|
Measures psychological readiness and fear of re-injury; strong internal consistency (α = 0.94) and test-retest reliability (ICC = 0.90)
|
At baseline After 6 weeks of intervention
|
|
Tampa Scale of Kinesiophobia (TSK)
Time Frame: at baseline at 6 weeks post intervention
|
Assesses fear of movement and re-injury; validated in musculoskeletal populations with good internal consistency (α = 0.810.87)
and test-retest reliability (ICC = 0.84-0.90)
|
at baseline at 6 weeks post intervention
|
|
Landing Error Scoring System (LESS)
Time Frame: at baseline at 6 weeks post intervention
|
The LESS is a movement screen used to identify specific movement patterns of the lower extremities that may increase an individual's risk for noncontact ACL injury
|
at baseline at 6 weeks post intervention
|
|
Reactive Strength Index (RSI)
Time Frame: at baseline 6 weeks post intervention
|
Measures reactive strength and stretch-shortening cycle efficiency; demonstrates good test-retest reliability (ICC = 0.87) in athletes.
|
at baseline 6 weeks post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ramsha Ali, Riphah International University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
December 25, 2026
Study Completion (Estimated)
January 5, 2027
Study Registration Dates
First Submitted
September 6, 2026
First Submitted That Met QC Criteria
September 6, 2026
First Posted (Actual)
September 11, 2026
Study Record Updates
Last Update Posted (Actual)
September 11, 2026
Last Update Submitted That Met QC Criteria
September 6, 2026
Last Verified
September 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Ramsha Ali
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.